Can liquid biopsy predict oropharyngeal cancer recurrence?March 3, 2022Head & Neck/Thyroid CancersMixed TopicsOncology
FDA approves new CAR T-cell treatment for multiple myelomaMarch 1, 2022Multiple MyelomaOncologyHematology
63% of patients with upper tract urothelial carcinoma respond to chemo before surgeryFebruary 24, 2022Genitourinary CancerOncology
Radiofrequency ablation an option for thyroid microcarcinomaFebruary 24, 2022Head & Neck/Thyroid CancersOncology
MRI far safer than CT for guiding radiotherapy in prostate cancerFebruary 24, 2022Genitourinary CancerOncologyProstate Cancer
Breast cancer trials enrolling now: Could your patient benefit?February 18, 2022Breast CancerOncology
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinomaFebruary 17, 2022Head & Neck/Thyroid CancersOncology
